1. Home
  2. RGP vs NMRA Comparison

RGP vs NMRA Comparison

Compare RGP & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

SELL

Current Price

$2.65

Market Cap

93.7M

ML Signal

SELL

Logo Neumora Therapeutics Inc.

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$0.33

Market Cap

87.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
NMRA
Founded
1996
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
93.7M
87.4M
IPO Year
2000
2023

Fundamental Metrics

Financial Performance
Metric
RGP
NMRA
Price
$2.65
$0.33
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
★ $6.50
$5.33
AVG Volume (30 Days)
261.7K
★ 1.5M
Earning Date
01-06-2027
11-16-2026
Dividend Yield
★ 10.41%
N/A
EPS Growth
★ 79.14
5.23
EPS
★ N/A
N/A
Revenue
★ $452,006,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.19
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.33
$0.32
52 Week High
$5.37
$3.65

Technical Indicators

Market Signals
Indicator
RGP
NMRA
Relative Strength Index (RSI) 38.90 30.94
Support Level $2.58 N/A
Resistance Level $2.85 $0.65
Average True Range (ATR) 0.10 0.08
MACD 0.04 0.00
Stochastic Oscillator 24.07 1.32

Price Performance

Historical Comparison
RGP
NMRA

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: